Amit Wagadia

Amit Wagadia has extensive experience in business development, with a focus on the pharmaceutical and clinical research industries. Amit is currently serving as the Senior Director of Business Development at tranScrip since July 2022. Prior to this, they worked at Aptus Clinical Ltd as the Director of Business Development from April 2020 to July 2022. From May 2018 to April 2020, Amit held the position of Director of Business Development at PharmaLex. Before joining PharmaLex, they worked at PAREXEL from June 2012 to May 2018, initially as an Account Manager in Customer Strategy and later as the Director of Business Development. Amit's career began at Catalent Pharma Solutions in May 2003, where they worked as a Formulation Scientist. Amit later joined Exova Group Limited as a Higher Formulation Scientist from May 2007 to April 2011. In May 2011, Amit worked as a Proposal Developer at Quintiles in the Global Sales Operations department for Clinical Development Services.

Amit Wagadia completed an MSc in Pharmaceutical Technology from King's College London in 2002. Prior to that, they obtained a MSci degree in Biomedical Sciences from the University of Southampton between 1997 and 2001.